A Fast-Moving Inherited Macular Dystrophy
A bridge whose support cables corrode unevenly along their length can force engineers into a hurried fix — bolting on a temporary brace that was never designed to bear real weight, and that gives way again almost as soon as traffic returns to normal. A similar chain of events plays out behind the retina with Sorsby fundus dystrophy: a defective protein makes Bruch's membrane thicken in a way it shouldn't, prompting the retina to force fresh blood vessels through that weakened point — vessels that are structurally unsound from the start and begin leaking almost as soon as they form. It's this early, out-of-place vessel growth — showing up decades before it normally would in age-related eye disease — that places Sorsby dystrophy among the more aggressive conditions discussed on this site.
When a Rwandan patient, typically in their thirties or forties, experiences central vision loss that unfolds across weeks instead of years, that speed alone is frequently the first sign suggesting Sorsby rather than a milder, more ordinary dystrophy.
The defining trait of this disease is honestly just its speed. One eye can lose meaningful central vision inside a few weeks; the other typically follows, sometimes years afterward. Patients describe straight lines that suddenly look crooked, a blur that spreads fast across the centre of their sight, and occasionally an odd struggle seeing in dim rooms that showed up quietly, well before anything more dramatic followed.
TIMP3 is the gene responsible, and under normal conditions it keeps tissue turnover around Bruch's membrane properly balanced. Once that balance fails, the membrane thickens where it shouldn't, and the retina reacts by forcing new vessels through the weakened spot — vessels that are fragile from the moment they form and start leaking almost immediately. A single faulty copy of TIMP3 from either parent is all it takes to set the whole process off.
A scatter of pale, yellow-white spots along the retinal vessels is typically the first thing an examiner spots during a routine fundus check. Attention then shifts to confirming active new vessel growth specifically — OCT angiography is usually enough, with fluorescein angiography reserved for cases needing a sharper look, since leaking vessels change how urgently things need to move. A TIMP3 genetic test confirms the cause, and given the pace this condition can take, that result gets treated as urgent rather than routine.
If active leaking vessels are found, dealing with them comes first, ahead of everything else in the plan. Once the eye stabilises, patients who qualify move into regenerative stem cell therapy aimed at supporting the retina going forward, and because Sorsby has a habit of moving quickly, follow-up visits happen more often here than they would for a slower dystrophy.
It absolutely can, and that unusually fast pace is one of the very clues that points specifically toward Sorsby dystrophy. Virtually every other inherited macular condition takes years rather than weeks to unfold, which is exactly why this particular speed stands out so clearly.
That kind of confusion isn't rare, given that both conditions can produce similar-looking leaking vessels on a scan. What genuinely separates the two is when it started, whether a family history is present, and a TIMP3 genetic test confirming the underlying cause.
We treat it as urgent, since vessels left leaking unchecked can cost additional vision within a short window. Getting that particular issue under control always takes precedence over everything else.
Not for certain — though the risk deserves serious attention, since this is a dominant condition, giving each child of an affected parent close to a fifty percent chance of carrying the faulty gene. Severity varies quite a bit from one person to another, and genetic testing can offer your family a sharper picture of where things stand.